NAVB Navidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

$1.09  -0.06 (-4.83%)
As of 12/07/2021 11:53:33 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/10/1992
Outstanding shares:  30,188,491
Average volume:  65,327
Market cap:   $34,716,765
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    63937X202
ISIN:        US63937X2027
Valuation   (See tab for details)
PE ratio:   -3.11
PB ratio:   10.09
PS ratio:   49.57
Return on equity:   -320.39%
Net income %:   -1,556.49%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy